Englander Institute for Precision Medicine

Publications

Found 805 results
Author Title Type [ Year(Asc)]
2024
Schwarz E, Benner B, Wesolowski R, Quiroga D, Good L, Sun SH, Savardekar H, Li J, Jung KJoo, Duggan MC et al..  2024.  Inhibition of Bruton's tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumors.. JCI Insight. 9(21)
Wolujewicz P, Aguiar-Pulido V, Thareja G, Suhre K, Elemento O, Finnell RH, M Ross E.  2024.  Integrative computational analyses implicate regulatory genomic elements contributing to spina bifida.. Genet Med Open. 2:101894.
Hissong E, Bhinder B, Kim J, Ohara K, Ravichandran H, Assaad MAl, Elsoukkary S, Shusterman M, Khan U, Eng KWha et al..  2024.  Integrative Transcriptomic and Single-Cell Protein Characterization of Colorectal Carcinoma Delineates Distinct Tumor Immune Microenvironments Associated with Overall Survival.. Res Sq.
Chen X, Tsvetkov AS, Shen H-M, Isidoro C, Ktistakis NT, Linkermann A, Koopman WJH, Simon H-U, Galluzzi L, Luo S et al..  2024.  International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis.. Autophagy.
Nguyen DD, Hooper WF, Liu W, Chu TR, Geiger H, Shelton JM, Shah M, Goldstein ZR, Winterkorn L, Helland A et al..  2024.  The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution.. Nature. 635(8037):219-228.
Yaron-Barir TM, Joughin BA, Huntsman EM, Kerelsky A, Cizin DM, Cohen BM, Regev A, Song J, Vasan N, Lin T-Y et al..  2024.  The intrinsic substrate specificity of the human tyrosine kinome.. Nature.
Vivelo C, Reilly KM, Widemann BC, Wedekind MFrances, Painter C, O'Neill AF, Mueller S, Elemento O, Gross AM, Sandler AB.  2024.  The Landscape of US and Global Rare Tumor Research Programs: A Systematic Review.. Oncologist. 29(2):106-116.
Charpentier M, Bloy N, Formenti SC, Galluzzi L, Demaria S.  2024.  Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids.. J Vis Exp. (206)
Li X-Q, Yamazaki T, He T, Alam MMasud, Liu J, Trivett AL, Sveinbjørnsson B, Rekdal Ø, Galluzzi L, Oppenheim JJ et al..  2024.  LTX-315 triggers anticancer immunity by inducing MyD88-dependent maturation of dendritic cells.. Front Immunol. 15:1332922.
Chaudhry F, Kim TWan, Elemento O, Betel D.  2024.  Machine learning analysis of population-wide plasma proteins identifies hormonal biomarkers of Parkinson's Disease.. medRxiv.
Gillessen S, Turco F, Davis ID, Efstathiou JA, Fizazi K, James ND, Shore N, Small E, Smith M, Sweeney CJ et al..  2024.  Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC).. Eur Urol.
Montrose DC, Saha S, Galluzzi L.  2024.  Metabolic regulation of the mitochondrial immune checkpoint.. Oncoimmunology. 13(1):2394247.
Pandey RS, Arnold M, Batra R, Krumsiek J, Kotredes KP, Garceau D, Williams H, Sasner M, Howell GR, Kaddurah-Daouk R et al..  2024.  Metabolomics profiling reveals distinct, sex-specific signatures in serum and brain metabolomes in mouse models of Alzheimer's disease.. Alzheimers Dement.
Guilbaud E, Galluzzi L.  2024.  A mitochondrial checkpoint to NF-κB signaling.. Cell Death Dis. 15(7):477.
Galassi C, Klapp V, Yamazaki T, Galluzzi L.  2024.  Molecular determinants of immunogenic cell death elicited by radiation therapy.. Immunol Rev. 321(1):20-32.
Sumiyoshi T, Wang X, Warner EW, Sboner A, Annala M, Sigouros M, Beja K, Mizuno K, Ku S, Fazli L et al..  2024.  Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial.. J Natl Cancer Inst. 116(1):115-126.
Beltrán-Visiedo M, Balachandran S, Galluzzi L.  2024.  MRE11 mobilizes CGAS and drives ZBP1-dependent necroptosis.. Cell Res.
Bojmar L, Zambirinis CP, Hernandez JM, Chakraborty J, Shaashua L, Kim J, Johnson KEnnu, Hanna S, Askan G, Burman J et al..  2024.  Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer.. Nat Med.
Liu J, Cao S, Imbach KJ, Gritsenko MA, Lih T-SM, Kyle JE, Yaron-Barir TM, Binder ZA, Li Y, Strunilin I et al..  2024.  Multi-scale signaling and tumor evolution in high-grade gliomas.. Cancer Cell. 42(7):1217-1238.e19.
Paul S, Sarraf SA, Nam KHong, Zavar L, DeFoor N, Biswas SRanjan, Fritsch LE, Yaron TM, Johnson JL, Huntsman EM et al..  2024.  NAK-associated protein 1/NAP1 activates TBK1 to ensure accurate mitosis and cytokinesis.. J Cell Biol. 223(2)
Suhre K, Venkataraman GRam, Guturu H, Halama A, Stephan N, Thareja G, Sarwath H, Motamedchaboki K, Donovan MKR, Siddiqui A et al..  2024.  Nanoparticle enrichment mass-spectrometry proteomics identifies protein-altering variants for precise pQTL mapping.. Nat Commun. 15(1):989.
Hissong E, Assaad MAl, Bal M, Reed KA, Fornelli A, Levine MF, Gundem G, Semaan A, Orr CE, Sakhadeo U et al..  2024.  NIPBL::NACC1 Fusion Hepatic Carcinoma.. Am J Surg Pathol. 48(2):183-193.
Franceschini GMarco, Quaini O, Mizuno K, Orlando F, Ciani Y, Ku S-Y, Sigouros M, Rothmann E, Alonso A, Benelli M et al..  2024.  Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation.. Cancer Discov. 14(3):424-445.
Stern LJ, Clement C, Galluzzi L, Santambrogio L.  2024.  Non-mutational neoantigens in disease.. Nat Immunol. 25(1):29-40.
de la Mora JDelgado-, Assaad MAl, Quitian S, Levine MF, Deshpande A, Sigouros M, Manohar J, Medina-Martínez JS, Sboner A, Elemento O et al..  2024.  Novel structural variants that impact cell cycle genes are elucidated in metastatic gastrointestinal stromal tumors.. Pathol Res Pract. 266:155782.